SYRS Syros Pharmaceuticals, Inc.
Healthcare$0.00-50.00%ClosedMarket Cap: $5,366
As of 2026-05-26
Insider Statistics (Q4 2024)
Acquisitions
5
Dispositions
16
Buy/Sell Ratio
0.31
Net Shares
-566,483
Shares Acquired
111,875
Shares Disposed
678,358
Total Bought ($)
$0.00
Total Sold ($)
$7.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Wed Dec 04 | Simonian Nancy A | director | Sell | 37,070 | $0.27 | 4,000 |
| Wed Nov 27 | Simonian Nancy A | director | Sell | 134,713 | $0.27 | 41,070 |
| Wed Nov 20 | Stephens Kristin | officer: Chief Development Officer | Sell | 36,133 | $0.22 | 0 |
| Wed Nov 20 | Roth David | officer: Chief Medical Officer | Sell | 12,099 | $0.20 | 0 |
| Wed Nov 20 | Quirk Gerald E | officer: Chief Legal & Compliance Offic | Sell | 46,657 | $0.22 | 0 |
| Wed Nov 20 | Haas Jason | officer: Chief Financial Officer | Sell | 137,803 | $0.21 | 0 |
| Wed Nov 20 | Chee Conley | director, officer: President & CEO | Sell | 134,797 | $0.20 | 0 |
| Mon Nov 04 | Simonian Nancy A | director | Sell | 40,125 | $0.00 | 175,783 |
| Mon Nov 04 | Roth David | officer: Chief Medical Officer | Sell | 18,875 | $0.00 | 18,875 |